Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Operating Margin (2016 - 2025)

Historic Operating Margin for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 55.87%.

  • Sanofi's Operating Margin rose 469600.0% to 55.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 11.79%, marking a year-over-year decrease of 69000.0%. This contributed to the annual value of 14.54% for FY2025, which is 31100.0% down from last year.
  • Latest data reveals that Sanofi reported Operating Margin of 55.87% as of Q4 2025, which was up 469600.0% from 22.84% recorded in Q3 2025.
  • In the past 5 years, Sanofi's Operating Margin ranged from a high of 99.36% in Q4 2022 and a low of 7.53% during Q2 2025
  • For the 5-year period, Sanofi's Operating Margin averaged around 25.54%, with its median value being 22.33% (2022).
  • As far as peak fluctuations go, Sanofi's Operating Margin tumbled by -1431000bps in 2021, and later surged by 846100bps in 2022.
  • Quarter analysis of 5 years shows Sanofi's Operating Margin stood at 14.75% in 2021, then surged by 574bps to 99.36% in 2022, then plummeted by -82bps to 18.28% in 2023, then crashed by -51bps to 8.91% in 2024, then surged by 527bps to 55.87% in 2025.
  • Its last three reported values are 55.87% in Q4 2025, 22.84% for Q3 2025, and 7.53% during Q2 2025.